Data as of Oct 24
| +0.34 / +1.50%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 23.00, with a high estimate of 25.00 and a low estimate of 21.00. The median estimate represents a +0.04% increase from the last price of 22.99.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.